Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apotea AB (publ)OSTO:APOTEA -0.82%18 Buyback Yield % is -0.04 as of Aug. 12, 2026. GuruFocus rates OSTO:APOTEA with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 265 Healthcare Providers & Services companies, Apotea AB (publ) ranks worse than 50.57% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Apotea AB (publ)'s Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) Buyback Yield % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apotea AB (publ) Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Apotea AB (publ)'s Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apotea AB (publ) (OSTO:APOTEA) has a Buyback Yield % of -0.04 as of Aug. 12, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Apotea AB (publ) and its competitors. According to the industry distribution chart, Apotea AB (publ) ranks #134 out of 265 companies in the Healthcare Providers & Services industry, placing it in the top 50.6%.
Is Apotea AB (publ)'s Buyback Yield % too high?
Apotea AB (publ)'s current Buyback Yield % is -0.04. Based on the distribution chart, Apotea AB (publ) ranks #134 out of 265 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Buyback Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #134 out of 265 companies for Buyback Yield %. This places Apotea AB (publ) in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Buyback Yield % is -0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (OSTO:APOTEA) has a current Buyback Yield % of -0.04. The current Buyback Yield % is -0.04. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Apotea AB (publ) (OSTO:APOTEA), the current Buyback Yield % is -0.04 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score
Get the complete analysis for OSTO:APOTEA
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:APOTEA has been successfully added to your 
